Merkel cell carcinoma (MCC) is a rare skin cancer, accounting for less than 1% of all
cutaneous malignancies. It is found predominantly in white populations and risk factors …

Rare cancers are a growing group as a result of reclassification of common cancers by
molecular markers. There is therefore an increasing need to identify methods to assess …

Abstract Background The first consensus Merkel cell carcinoma (MCC) staging system was
published in 2010. New information on the clinical course prompts review of MCC staging …

This selection from the NCCN Guidelines for Merkel Cell Carcinoma (MCC) focuses on
areas impacted by recently emerging data, including sections describing MCC risk factors …

Merkel cell carcinoma is a cutaneous neuroendocrine neoplasm that has been poorly
studied in contemporary cohorts. Patients with Merkel cell carcinoma from 1986 to 2011 …

Merkel cell carcinoma (MCC) is a rare aggressive cutaneous neuroendocrine malignancy
that frequently metastasizes to the regional lymphatic basin. Pathological assessment of …

Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous malignancy of
neuroendocrine origin. It was first described in 1972 by Toker, 1 who named it “trabecular …

Merkel cell carcinoma (MCC) is a rare cancer of the skin characterized by a neuroendocrine
phenotype and an aggressive clinical behavior. It frequently originates in sun-exposed body …

Merkel cell carcinoma (MCC) is a rare and aggressive skin cancer with a neuroendocrine
phenotype. Incidence varies according to the geographic regions but is overall increasing …

Background Sentinel lymph-node (LN) biopsy (SLNB) is a valuable tool to assess the
regional LN status in Merkel cell carcinoma (MCC). However, its prognostic value is still …